Epitope mapping and specificity of the anti-α-synuclein monoclonal antibody Syn-1 in mouse brain and cultured cell lines

Neuroscience Letters

Volumn 349, Issue 2, 2003, Pages 133-135

  Perrin, R J ^a,b   Payton, J E ^a   Barnett, D H ^a   Wraight, C L ^a   Woods, W S ^b   Ye, L ^a   George, J M ^b  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^b UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

Breast cancer; Dopaminergic; Immunoreactivity; Knockout; Parkinson's disease; Synuclein

Indexed keywords

ALPHA SYNUCLEIN; ALPHA SYNUCLEIN ANTIBODY; BETA SYNUCLEIN; BRAIN EXTRACT; EPITOPE; MONOCLONAL ANTIBODY; UNCLASSIFIED DRUG; NERVE PROTEIN; RECOMBINANT PROTEIN; SNCA PROTEIN, HUMAN; SNCA PROTEIN, MOUSE; SNCA PROTEIN, RAT; SNCB PROTEIN, HUMAN; SNCB PROTEIN, MOUSE; SNCB PROTEIN, RAT; SYNUCLEIN;

AMINO ACID SEQUENCE; ANIMAL TISSUE; ANTIBODY SPECIFICITY; ARTICLE; BRAIN HOMOGENATE; BRAIN TISSUE; CELL CULTURE; CELL LINE; CONTROLLED STUDY; CROSS REACTION; EPITOPE MAPPING; HUMAN; HUMAN CELL; IMMUNOREACTIVITY; MOLECULAR WEIGHT; MOUSE; NONHUMAN; NULL ALLELE; PRIORITY JOURNAL; PROTEIN DOMAIN; SEQUENCE ANALYSIS; WILD TYPE; ANIMAL; BRAIN; COMPARATIVE STUDY; GENETICS; IMMUNOBLOTTING; IMMUNOLOGY; METABOLISM; MOUSE MUTANT; MUTATION; RAT; SPECIES DIFFERENCE;

ALPHA-SYNUCLEIN; ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODY SPECIFICITY; BETA-SYNUCLEIN; BRAIN; CELLS, CULTURED; EPITOPE MAPPING; HUMANS; IMMUNOBLOTTING; MICE; MICE, KNOCKOUT; MUTATION; NERVE TISSUE PROTEINS; RATS; RECOMBINANT PROTEINS; SPECIES SPECIFICITY; SYNUCLEINS;

EID: 0142058187     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(03)00781-X     Document Type: Article

References (10)

1. Dauer W., Kholodilov N., Vila M., Trillat A.C., Goodchild R., Larsen K.E., Staal R., Tieu K., Schmitz Y., Yuan C.A., Rocha M., Jackson-Lewis V., Hersch S., Sulzer D., Przedborski S., Burke R., Hen R. Resistance of alpha-synuclein null mice to the parkinsonian neurotoxin MPTP. Proc. Natl. Acad. Sci. USA. 99:2002;14524-14529.
2. George J.M., Jin H., Woods W.S., Clayton D.F. Characterization of a novel protein regulated during the critical period for song learning in the zebra finch. Neuron. 15:1995;361-372.
3. Gomez-Santos C., Ferrer I., Reiriz J., Vinals F., Barrachina M., Ambrosio S. MPP+ increases alpha-synuclein expression and ERK/MAP-kinase phosphorylation in human neuroblastoma SH-SY5Y cells. Brain Res. 935:2002;32-39.
4. Irizarry M.C., Growdon W., Gomez-Isla T., Newell K., George J.M., Clayton D.F., Hyman B.T. Nigral and cortical Lewy bodies and dystrophic nigral neurites in Parkinson's disease and cortical Lewy body disease contain alpha-synuclein immunoreactivity. J. Neuropathol. Exp. Neurol. 57:1998;334-337.
5. Irizarry M.C., Kim T.W., McNamara M., Tanzi R.E., George J.M., Clayton D.F., Hyman B.T. Characterization of the precursor protein of the non-A beta component of senile plaques (NACP) in the human central nervous system. J. Neuropathol. Exp. Neurol. 55:1996;889-895.
6. Jakowec M.W., Donaldson D.M., Barba J., Petzinger G.M. Postnatal expression of alpha-synuclein protein in the rodent substantia nigra and striatum. Dev. Neurosci. 23:2001;91-99.
7. Leng Y., Chase T.N., Bennett M.C. Muscarinic receptor stimulation induces translocation of an alpha-synuclein oligomer from plasma membrane to a light vesicle fraction in cytoplasm. J. Biol. Chem. 276:2001;28212-28218.
8. Perrin R.J., Woods W.S., Clayton D.F., George J.M. Interaction of human α-synuclein and Parkinson's disease variants with phospholipids. Structural analysis using site-directed mutagenesis. J. Biol. Chem. 275:2000;34393-34398.
9. Rideout H.J., Larsen K.E., Sulzer D., Stefanis L. Proteasomal inhibition leads to formation of ubiquitin/alpha-synuclein-immunoreactive inclusions in PC12 cells. J. Neurochem. 78:2001;899-908.
10. Stefanova N., Klimaschewski L., Poewe W., Wenning G.K., Reindl M. Glial cell death induced by overexpression of alpha-synuclein. J. Neurosci. Res. 65:2001;432-438.